4-Hydroxy-2-(trifluoromethyl)benzonitrile, 98.0%, 25g

(2R,4R)-1-[(tert-Butoxy)carbonyl]-2-methylpiperidine-4-carboxylic acid, 98%, 100mg

1,3-Dibromoadamantane, 95.0%, 100g

(4R,4'R)-2,2'-(Cyclohexane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97% 99%ee, 250mg

1-[(4-chlorophenyl)methyl]-3-nitro-1H-pyrazole, 95.0%, 1g

7-Bromo-2-chloro-1,6-naphthyridine, 95%, 1g

Ethyl 5-bromo-6-chloropicolinate, 95.0%, 25g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 98%, 1g

N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 97.0%, 5g

(R)-2-(Methylamino)propanoic acid hydrochloride, 95.0%, 1g

Piperidina, min 99%, per sintesi, 250 ml, confezione in vetro

6-Fluoronicotinic Acid>98.0%(GC)5g

2,4-Mesitylenedisulfonyl Dichloride>98.0%(T)25g